Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 15;8(2):2334-41.
eCollection 2015.

Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro

Affiliations

Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro

Ze-Ya Pan et al. Int J Clin Exp Med. .

Retraction in

Abstract

Tumor protein D52-like 2, known as hD54 in previous studies (TPD52L2), is a member of TPD52 family which has been implicated in multiple human cancers. In recent reports, TPD52 proteins were indicated to be associated with several malignancies, but very little is known about the function of TPD52L2 in liver cancers. In our present study, in order to explore the role of TPD52L2 in liver cancer, TPD52L2 was knocked down in SMMC-7721 liver cancer cell line by lentivirus mediated RNA interference. The results demonstrated that depletion of TPD52L2 could remarkably inhibit proliferation and colony forming ability of cancer cell SMMC-7721. Furthermore, cell cycle in TPD52L2 depleted cells was verified to be arrested in G0/G1 phase as determined by FACS assay, in consistence with the observation of cell proliferation inhibition. These results unraveled that TPD52L2 played an important role in tumorigenesis pathways of liver cancer and might serve as a promising target in human liver cancer diagnosis and therapy.

Keywords: RNA interference; TPD52L2; lentivirus; liver cancer; proliferation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lentivirus infection and knockdown efficiency of SMMC-7721 cells. A: Bright field and fluorescence photomicrographs after transduction of SMMC-7721 cells in Con, shCon and shTPD52L2 groups respectively. Over 80% of cells were infected with lentivirus by visualized GFP expression. Scale bar: 100 µm. B: Relative expression level of TPD52L2 in SMMC-7721 cells with quantitative PCR. **P < 0.01, compared to shCon. C: Western blot analysis of TPD52L2 to present a satisfying knockdown efficiency.
Figure 2
Figure 2
Colony formation ability and proliferation rate of SMMC-7721 cells with TPD52L2 silencing. A: Line chart of MTT assay by optical density at 595 nm of SMMC-7721 cells in Con, shCon and shTPD52L2 groups respectively. ***P < 0.001, compared to shCon. B: The colony formation of SMMC-7721 cells in Con, shCon and shTPD52L2 groups viewing under bright field, crystal violet, fluorescent field (Scale bar: 250 µm), and six-well plate respectively. C: The statistical analysis of colony numbers in Con, shCon and shTPD52L2 groups. ***P < 0.001, compared to shCon.
Figure 3
Figure 3
Depletion of TPD52L2 triggered G0/G1 cell cycle arrest. A: Cell cycle distribution of SMMC-7721 cells by flow cytometry in Con, shCon and shTPD52L2 groups respectively. B: Cell population under different stages of G0/G1, S, G2/M phase. ***P < 0.001, compared to shCon. C: Variant distribution of SMMC-7721 cells of Con, shCon, and shTPD52L2 in sub-G1 phase. **P < 0.01, compared to shCon.

Similar articles

Cited by

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. - PMC - PubMed
    1. Luke C, Price T, Roder D. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population. Asian Pac J Cancer Prev. 2010;11:1479–1485. - PubMed
    1. Katanoda K, Matsuda T. Five-year relative survival rate of liver cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2014;44:302–303. - PubMed
    1. Li G, Xiao Z, Liu J, Li C, Li F, Chen Z. Cancer: a proteomic disease. Sci China Life Sci. 2011;54:403–408. - PubMed

Publication types

LinkOut - more resources